{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:06:51Z","timestamp":1788314811668,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Penn State Clinical & Translational Science Institute, Pennsylvania State University"},{"name":"NIH\/NCATS","award":["UL1 TR000127"],"award-info":[{"award-number":["UL1 TR000127"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K23 DA045081"],"award-info":[{"award-number":["K23 DA045081"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>IQOS was authorized by the U.S. Food and Drug Administration (FDA) as a modified-risk tobacco product. We conducted a pharmacokinetic study evaluating the nicotine delivery and subjective effects of IQOS use among current menthol cigarette smokers to better understand if IQOS is an acceptable cigarette alternative in light of the proposed menthol cigarette ban.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims and Methods<\/jats:title>\n                  <jats:p>Participants were adult smokers of &amp;gt;4 menthol cigarettes per day. After 14-hour nicotine abstinence, participants were provided an IQOS device and menthol heatstick to puff every 20 seconds for a total of 14 puffs. Blood samples were collected at baseline and during active use to calculate nicotine boost from baseline to peak concentration. Nicotine withdrawal symptoms were collected before and after IQOS use. In addition, a modified Product Evaluation Scale for IQOS was collected after use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Participants (n = 8) were a mean age of 43.9 years, 63% were female, 88% identified as White, and they smoked a mean of 17.1 menthol cigarettes per day. After IQOS use, the mean nicotine boost obtained was 15.96 ng\/mL (SD = 6.91) (range 9.31 to 30.55 ng\/mL). Most (75%) participants reported enjoying use of the product \u201ca lot\u201d or greater and more than half (62.5%) reported reduced cigarette cravings. Most participants reported no side effects after use; however, two experienced dry mouth, three experienced dizziness, one experienced throat irritation, and one experienced headache.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We found that directed use (14 puffs) of menthol IQOS delivered a mean nicotine boost of 15.96 ng\/mL which reduced craving for a cigarette. The majority of participants enjoyed use of IQOS and reported mild side effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications<\/jats:title>\n                  <jats:p>Menthol IQOS delivered a sufficient dose of nicotine perceived as satisfying by menthol cigarette smokers and it reduced craving with mild side effects. Menthol IQOS has potential to serve as a less harmful alternative for menthol cigarette smokers. The availability of modified risk products like IQOS should be considered by FDA\u2019s Comprehensive Plan for Tobacco and Nicotine Regulation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ntr\/ntad119","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T07:41:31Z","timestamp":1689147691000},"page":"397-401","source":"Crossref","is-referenced-by-count":7,"title":["Nicotine Delivery of a Menthol-Flavored Heat-not-Burn Tobacco Product During Directed Use"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-668X","authenticated-orcid":false,"given":"Jessica M","family":"Yingst","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Bordner","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Hrabovsky","sequence":"additional","affiliation":[{"name":"Penn State University College of Nursing, University Park, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3020-3963","authenticated-orcid":false,"given":"Andrea L","family":"Hobkirk","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Health, Penn State College of Medicine , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Trushin","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John P","family":"Richie","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2296-0726","authenticated-orcid":false,"given":"Jonathan","family":"Foulds","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine , Hershey, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"2024022210051158300_CIT0001","author":"Food and Drug Administration","year":"2020"},{"issue":"7","key":"2024022210051158300_CIT0002","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/acs.chemrestox.0c00088","article-title":"Free radical production and characterization of heat-not-burn cigarettes in comparison to conventional and electronic cigarettes","volume":"33","author":"Bitzer","year":"2020","journal-title":"Chem Res Toxicol."},{"issue":"11","key":"2024022210051158300_CIT0003","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/add.14365","article-title":"Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e-cigarette and a tobacco cigarette","volume":"113","author":"Farsalinos","year":"2018","journal-title":"Addiction."},{"issue":"1","key":"2024022210051158300_CIT0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12931-018-0867-z","article-title":"Carbon monoxide levels after inhalation from new generation heated tobacco products","volume":"19","author":"Caponnetto","year":"2018","journal-title":"Respir Res."},{"issue":"5","key":"2024022210051158300_CIT0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/tobaccocontrol-2018-054419","article-title":"Heat-not-burn tobacco products: a systematic literature review","volume":"28","author":"Simonavicius","year":"2019","journal-title":"Tob Control."},{"key":"2024022210051158300_CIT0006","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/tobaccocontrol-2019-055475","article-title":"Acute effects of JUUL and IQOS in cigarette smokers","volume":"30","author":"Maloney","year":"2020","journal-title":"Tob Control."},{"issue":"7","key":"2024022210051158300_CIT0007","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/ntr\/nts265","article-title":"Subjective responses to oral tobacco products: scale validation","volume":"15","author":"Hatsukami","year":"2013","journal-title":"Nicotine Tob Res."},{"issue":"3","key":"2024022210051158300_CIT0008","doi-asserted-by":"crossref","first-page":"L425","DOI":"10.1152\/ajplung.00343.2016","article-title":"Biomarkers of exposure to new and emerging tobacco delivery products","volume":"313","author":"Schick","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"9","key":"2024022210051158300_CIT0009","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3390\/ijerph17093225","article-title":"Characteristic human individual puffing profiles can generate more TNCO than ISO and health canada regimes on smoking machine when the same brand is smoked","volume":"17","author":"Pauwels","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"2024022210051158300_CIT0010","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1158\/1055-9965.EPI-14-0280","article-title":"Make your own cigarettes: toxicant exposure, smoking topography, and subjective effects","volume":"23","author":"Koszowski","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"2","key":"2024022210051158300_CIT0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ntr\/ntz045","article-title":"Pharmacokinetic profile of spectrum reduced nicotine cigarettes","volume":"22","author":"Kamens","year":"2020","journal-title":"Nicotine Tob Res."},{"issue":"11","key":"2024022210051158300_CIT0012","doi-asserted-by":"crossref","first-page":"e1915494","DOI":"10.1001\/jamanetworkopen.2019.15494","article-title":"Nicotine absorption profile among regular users of a pod-based electronic nicotine delivery system","volume":"2","author":"Yingst","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2024022210051158300_CIT0013","doi-asserted-by":"crossref","first-page":"e0220300","DOI":"10.1371\/journal.pone.0220300","article-title":"Nicotine absorption during electronic cigarette use among regular users","volume":"14","author":"Foulds","year":"2019","journal-title":"PLoS One."},{"issue":"3","key":"2024022210051158300_CIT0014","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry."},{"issue":"3-4","key":"2024022210051158300_CIT0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jchromb.2010.12.012","article-title":"Determination of the nicotine metabolites cotinine and trans-3\u2019-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity","volume":"879","author":"Jacob","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"2024022210051158300_CIT0016","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/jcph.1915","article-title":"Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): implications for benefits and risks in the promotion of the combusted tobacco endgame","volume":"61","author":"Benowitz","year":"2021","journal-title":"J Clin Pharmacol."},{"issue":"19","key":"2024022210051158300_CIT0017","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxrep.2020.12.016","article-title":"Nicotine pharmacokinetics of electronic cigarettes: a pooled data analysis from the literature","volume":"8","author":"Jacobson","year":"2021","journal-title":"Toxicol Rep."},{"issue":"1","key":"2024022210051158300_CIT0018","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/10826084.2020.1834582","article-title":"Dependence and use characteristics of adult JUUL electronic cigarette users","volume":"56","author":"Yingst","year":"2021","journal-title":"Subst Use Misuse."},{"issue":"3","key":"2024022210051158300_CIT0019","first-page":"261","article-title":"The use of the nicotine metabolite ratio as a biomarker to personalize smoking cessation treatment: current evidence and future directions","volume":"13","author":"Siegel","year":"2020","journal-title":"CAPR"},{"issue":"11","key":"2024022210051158300_CIT0020","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/ntr\/ntab094","article-title":"Nicotine delivery and user ratings of iqos heated tobacco system compared with cigarettes, juul, and refillable E-cigarettes","volume":"23","author":"Phillips-Waller","year":"2021","journal-title":"Nicotine Tob Res."},{"issue":"1","key":"2024022210051158300_CIT0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/tobaccocontrol-2019-055306","article-title":"Factors that influence smokers\u2019 and ex-smokers\u2019 use of IQOS: a qualitative study of IQOS users and ex-users in the UK","volume":"30","author":"Tompkins","year":"2021","journal-title":"Tob Control."},{"issue":"e1","key":"2024022210051158300_CIT0022","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/tobaccocontrol-2020-056367","article-title":"Nicotine delivery and cigarette equivalents from vaping a JUULpod","volume":"31","author":"Prochaska","year":"2022","journal-title":"Tob Control."},{"issue":"6","key":"2024022210051158300_CIT0023","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/ntr\/ntab001","article-title":"An open-label, randomized, controlled, crossover study to assess nicotine pharmacokinetics and subjective effects of the JUUL system with three nicotine concentrations relative to combustible cigarettes in adult smokers","volume":"23","author":"Goldenson","year":"2021","journal-title":"Nicotine Tob Res."},{"issue":"1","key":"2024022210051158300_CIT0024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12954-022-00638-0","article-title":"A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI\u00ae stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers","volume":"19","author":"Fearon","year":"2022","journal-title":"Harm Reduct J"},{"issue":"8","key":"2024022210051158300_CIT0025","doi-asserted-by":"crossref","first-page":"e2013601","DOI":"10.1001\/jamanetworkopen.2020.13601","article-title":"Assessment of menthol and nonmenthol cigarette consumption in the US, 2000 to 2018","volume":"3","author":"Delnevo","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["Nicotine and Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntad119\/50929261\/ntad119.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/26\/3\/397\/56703969\/ntad119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/26\/3\/397\/56703969\/ntad119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T18:20:24Z","timestamp":1708626024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/26\/3\/397\/7223026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,7,12]]},"published-print":{"date-parts":[[2024,2,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntad119","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,7,12]]}}}